When Patty Gilbreath got the news, she thought her life might be over. The diagnosis was lung cancer. “It’s devastating. Your life is put on hold. You just think it’s done,” Ms. Gilbreath recalled. But today – just a few weeks after that life-changing news – the 59-year-old Davenport woman is cancer-free. That’s because on […]
Already a subscriber? Log in
Want to Read More?
Get immediate, unlimited access to all subscriber content and much more.
Learn more in our subscriber FAQ.
- Unparalleled business coverage of the Iowa City / Cedar Rapids corridor.
- Immediate access to subscriber-only content on our website.
- 52 issues per year delivered digitally, in print or both.
- Support locally owned and operated journalism.
When Patty Gilbreath got the news, she thought her life might be over.
The diagnosis was lung cancer.
“It’s devastating. Your life is put on hold. You just think it’s done,” Ms. Gilbreath recalled.
But today – just a few weeks after that life-changing news – the 59-year-old Davenport woman is cancer-free. That’s because on Wednesday, Nov. 9, Ms. Gilbreath had surgery at Genesis Health Systems in Davenport to remove a lobe of her lung containing two cancerous lung nodules.
That good news was made possible, in large part, because of new robotic-era technology called the Ion by Intuitive, a robotic-assisted platform for minimally invasive lung biopsies. The high-tech device makes it easier for doctors to obtain tissue samples for early detection of lung cancer. And early detection is a big key to survival for patients like Ms. Gilbreath, said Dr. Brian Witt of Genesis Pulmonary Associates.
Dr. Witt was among the medical professionals who helped unveil the Ion robotic technology during a news conference Tuesday morning, Dec. 20, at Genesis Medical Center-East Campus, Davenport.
The hospital is the first in the Quad-Cities region to offer the technology for minimally invasive lung biopsies that enables doctors to more easily obtain tissue samples for early detection and staging of lung cancer.
“Ion navigational bronchoscopy is a significant advancement in the early detection of lung cancer for our patients,” Dr. Witt said in a statement regarding the high-tech device. “It gives pulmonologists a minimally invasive way to access areas of the lung that previously were nearly impossible to reach and to biopsy lung nodules for an immediate diagnosis. Detecting lung cancer at an earlier stage can improve outcomes for patients and give them a better chance of survival.”
The robotic device represents a nearly $500,000 financial investment for Genesis, but “that’s a small capital investment” for the medical benefits it offers, Genesis Medical Center President Jordan Voigt told the QCBJ on Tuesday.
Those medical benefits made possible by the new technology center include: much faster detection of lung cancer (and faster detection of conditions that are not cancer); faster recovery for patients; less pain; shorter hospital stays; and less scar tissue, said Dr. Kurt Andersen, Genesis’ chief clinical officer/chief medical officer. Dr. Andersen was recently named as the health system’s next president and CEO with the impending retirement of Doug Cropper.
“The robots don’t do all the work. Physicians are also there,” Dr. Andersen added.
Genesis has one Ion device with no immediate plans to buy additional devices. Dr. Witt said the Ion has a fast “turnaround” time of about 45 minutes, which means it can easily be used for patients in back-to-back procedures.
Prior to Ion, a common way to identify and biopsy suspicious lung nodules was to use live CT scan imaging and a needle, entering the chest wall and lung from the outside of the body. This biopsy method carries a significant risk of collapsing the lung, which can require hospitalization for some patients. Ion’s minimally invasive lung biopsy is safer for patients, according to information from Genesis.